文献速递乳房整形与再造创面修复

乳房重建后皮炎:一种可管理的术后皮肤并发症

Post-reconstruction dermatitis of the breast.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2017-05-20

该回顾性分析描述了21例乳房切除术后行扩张器/假体或TRAM皮瓣重建后出现皮疹的患者,平均发病时间为重建后25.7个月。皮损表现为斑丘疹或鳞屑性红斑和斑块,5例培养均为阴性。局部糖皮质激素和抗生素治疗使所有随访患者完全或部分缓解,提示张力及术后因素可能致病。

要点

  • 乳房重建后皮疹平均在术后25.7个月出现,表现为斑丘疹或红斑鳞屑。
  • 皮损处培养常阴性,皮肤活检因张力区域相对禁忌,仅用于不响应皮损。
  • 局部糖皮质激素和抗生素可完全或部分缓解,恢复皮肤屏障并减少继发感染。

核心结论

  • 乳房重建后皮炎是一种可管理的疾病,发生于重建后数周至数年,局部糖皮质激素和抗生素治疗有效。

研究设计与样本

  • 回顾性分析21例因乳房切除术后行扩张器或假体置入或TRAM皮瓣重建后出现皮疹而转诊至皮肤科的患者。

主要发现

  • 平均发病时间为扩张器置入或TRAM皮瓣重建后25.7个月。
  • 临床表现包括斑丘疹或鳞屑性红斑和斑块。
  • 5例患者行皮疹培养,结果均为阴性。
  • 皮肤活检在皮肤张力区域相对禁忌,仅用于不响应皮损。

关键数值与推荐

  • 局部糖皮质激素和局部抗生素治疗使所有有随访记录的患者达到完全或部分缓解。

临床怎么用

  • 对于乳房重建后数周至数年出现的皮疹,可考虑局部糖皮质激素和抗生素治疗,以恢复皮肤屏障并减少继发感染。

局限性

  • 回顾性分析,样本量21例,部分患者缺乏随访记录。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Approximately one-third of women diagnosed with breast cancer undergo mastectomy with subsequent implant-based or autogenous tissue-based reconstruction. Potential complications include infection, capsular contracture, and leak or rupture of implants with necessity for explantation. Skin rashes are infrequently described complications of patients who undergo mastectomy with or without reconstruction. METHODS: A retrospective analysis of breast cancer patients referred to the Dermatology Service for diagnosis and management of a rash post-mastectomy and expander or implant placement or transverse rectus abdominis myocutaneous (TRAM) flap reconstruction was performed. Parameters studied included reconstruction types, time to onset, clinical presentation, associated symptoms, results of microbiologic studies, management, and outcome. RESULTS: We describe 21 patients who developed a rash on the skin overlying a breast reconstruction. Average time to onset was 25.7 months after expander placement or TRAM flap reconstruction. Clinical presentations included macules and papules or scaly, erythematous patches and plaques. Five patients had cultures of the rash, which were all negative. Skin biopsy was relatively contraindicated in areas of skin tension, and was reserved for non-responding eruptions. Treatments included topical corticosteroids and topical antibiotics, which resulted in complete or partial responses in all patients with documented follow-ups. CONCLUSION: Our findings suggest that tension and post-surgical factors play a causal role in this hitherto undescribed entity: "post-reconstruction dermatitis of the breast." This is a manageable condition that develops weeks to years following breast reconstruction. Topical corticosteroids and antibiotics result in restoration of skin barrier integrity and decreased secondary infection.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Rosen AC, Goh C, Lacouture ME, et al. Post-reconstruction dermatitis of the breast. J Plast Reconstr Aesthet Surg. 2017. PMID: 28602267. doi:10.1016/j.bjps.2017.05.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。